Kymera Therapeutics, Inc.
KYMR
$117.39
$2.972.60%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 690.99M | 650.93M | 848.28M | 505.68M | 665.45M |
| Total Receivables | 20.00M | -- | -- | -- | 40.00M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 26.28M | 26.50M | 22.94M | 22.62M | 22.88M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 737.27M | 677.43M | 871.21M | 528.30M | 728.33M |
|
|
|||||
| Total Current Assets | 737.27M | 677.43M | 871.21M | 528.30M | 728.33M |
| Net Property, Plant & Equipment | 81.07M | 83.35M | 85.53M | 88.08M | 94.62M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 13.21M | 13.51M | 14.91M | 12.62M | 10.50M |
| Total Assets | 1.65B | 1.67B | 1.74B | 1.10B | 1.13B |
|
|
|||||
| Total Accounts Payable | 8.92M | 12.84M | 4.02M | 5.51M | 5.78M |
| Total Accrued Expenses | 48.48M | 35.10M | 42.27M | 28.64M | 27.98M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.70M | 13.73M | 13.76M | 13.74M | 13.67M |
| Total Finance Division Other Current Liabilities | 236.00K | 976.00K | 23.17M | 23.69M | 40.12M |
| Total Other Current Liabilities | 236.00K | 976.00K | 23.17M | 23.69M | 40.12M |
| Total Current Liabilities | 71.33M | 62.64M | 83.21M | 71.58M | 87.54M |
|
|
|||||
| Total Current Liabilities | 71.33M | 62.64M | 83.21M | 71.58M | 87.54M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 64.86M | 66.74M | 68.50M | 70.25M | 72.05M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 11.44M | 13.96M | -- |
| Total Liabilities | 136.19M | 129.38M | 163.15M | 155.79M | 159.59M |
|
|
|||||
| Common Stock & APIC | 2.71B | 2.68B | 2.64B | 1.92B | 1.87B |
| Retained Earnings | -1.20B | -1.14B | -1.07B | -978.98M | -896.81M |
| Treasury Stock & Other | -7.16M | -4.19M | 1.80M | 1.50M | 279.00K |
| Total Common Equity | 1.51B | 1.54B | 1.58B | 946.26M | 971.48M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.51B | 1.54B | 1.58B | 946.26M | 971.48M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.51B | 1.54B | 1.58B | 946.26M | 971.48M |
|
|
|||||